IDEAYA Biosciences, Inc. (IDYA)
33.22
-0.63
(-1.86%)
USD |
NASDAQ |
Oct 16, 10:47
IDEAYA Biosciences SG&A Expense (TTM) : 77.07M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 77.07M |
| March 31, 2026 | 69.19M |
| December 31, 2025 | 63.32M |
| September 30, 2025 | 55.43M |
| June 30, 2025 | 48.78M |
| March 31, 2025 | 44.59M |
| December 31, 2024 | 39.30M |
| September 30, 2024 | 35.42M |
| June 30, 2024 | 33.54M |
| March 31, 2024 | 30.22M |
| December 31, 2023 | 28.31M |
| September 30, 2023 | 26.99M |
| June 30, 2023 | 25.79M |
| March 31, 2023 | 24.27M |
| December 31, 2022 | 23.90M |
| September 30, 2022 | 23.37M |
| June 30, 2022 | 21.89M |
| Date | Value |
|---|---|
| March 31, 2022 | 21.16M |
| December 31, 2021 | 20.05M |
| September 30, 2021 | 18.63M |
| June 30, 2021 | 17.38M |
| March 31, 2021 | 16.55M |
| December 31, 2020 | 15.18M |
| September 30, 2020 | 14.16M |
| June 30, 2020 | 12.92M |
| March 31, 2020 | 11.31M |
| December 31, 2019 | 9.952M |
| September 30, 2019 | 7.174M |
| June 30, 2019 | 5.562M |
| March 31, 2019 | 4.325M |
| December 31, 2018 | 3.112M |
| September 30, 2018 | 3.112M |
| June 30, 2018 | 2.024M |
| March 31, 2018 | 0.885M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Xencor, Inc. | 65.28M |
| BioMarin Pharmaceutical, Inc. | 1.368B |
| MediciNova, Inc. | 6.780M |
| Viking Therapeutics, Inc. | 50.70M |